Mezigdomide,Bortezomib,Dexamethasone,Daratumumab,Carfilzomib,Elotuzumab,Isatuximab
BMS,Takeda,Janssen,Amgen,Sanofi
['nct03989414', 'mezigdomide', 'mm-001', ' pom ', 'cc-92480', 'celmod']
.#568 mezigdomide (cc-92480), a potent, novel cereblon e3 ligase modulator (celmod), combined with dex in pts with rrmm preliminary results from the doseexpansion phase of the cc-92480-mm-001 trial #ash22 #imfash22 #myeloma 
VP Support Groups @IMFmyeloma. Husband, @IMFmikeMYELOMA dx w/ #myeloma 2000. The views & opinions expressed are my own & do not express views of my employer.